273 related articles for article (PubMed ID: 33785362)
1. Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes.
Almangour TA; Garcia E; Zhou Q; Forrest A; Kaye KS; Li J; Velkov T; Rao GG
Int J Antimicrob Agents; 2021 Jun; 57(6):106328. PubMed ID: 33785362
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant Gram-negative infections: what are the treatment options?
Giamarellou H; Poulakou G
Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006
[TBL] [Abstract][Full Text] [Related]
3. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Falagas ME; Kasiakou SK
Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
[TBL] [Abstract][Full Text] [Related]
4. Synergistic combinations of polymyxins.
Lenhard JR; Nation RL; Tsuji BT
Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
[TBL] [Abstract][Full Text] [Related]
5. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
Karakonstantis S; Kritsotakis EI; Gikas A
Infection; 2020 Dec; 48(6):835-851. PubMed ID: 32875545
[TBL] [Abstract][Full Text] [Related]
7. Polymyxins: Antimicrobial susceptibility concerns and therapeutic options.
Balaji V; Jeremiah SS; Baliga PR
Indian J Med Microbiol; 2011; 29(3):230-42. PubMed ID: 21860102
[TBL] [Abstract][Full Text] [Related]
8. Resistance to polymyxins in Gram-negative organisms.
Jeannot K; Bolard A; Plésiat P
Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients.
Lin YW; Aye SM; Rao G; Zhou QT; Chan HK; Li J
Int J Antimicrob Agents; 2020 Dec; 56(6):106199. PubMed ID: 33075510
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
Paterson DL; Bonomo RA
Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
[TBL] [Abstract][Full Text] [Related]
11. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
12. Reviving Polymyxins: Achievements, Lessons and the Road Ahead.
Li J
Adv Exp Med Biol; 2019; 1145():1-8. PubMed ID: 31364067
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
Zavascki AP; Goldani LZ; Li J; Nation RL
J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
[TBL] [Abstract][Full Text] [Related]
14. Colistin and polymyxin B in critical care.
Michalopoulos A; Falagas ME
Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
[TBL] [Abstract][Full Text] [Related]
15. Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: which is the best strategy to treat?
Sarda C; Fazal F; Rello J
Expert Rev Respir Med; 2019 Aug; 13(8):787-798. PubMed ID: 31210549
[No Abstract] [Full Text] [Related]
16. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
[TBL] [Abstract][Full Text] [Related]
17. Inhaled colistin for lower respiratory tract infections.
Antoniu SA; Cojocaru I
Expert Opin Drug Deliv; 2012 Mar; 9(3):333-42. PubMed ID: 22332963
[TBL] [Abstract][Full Text] [Related]
18. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
19. Polymyxins: older antibiotics for a new threat.
Lee SY; Kuti JL; Nicolau DP
Conn Med; 2006 Jan; 70(1):25-8. PubMed ID: 16479873
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
